Management of May Thurner Syndrome in Pregnant Patients

May Thurner Syndrome contributes to thromboembolic disease and can cause significant morbidity in pregnant patients secondary to exaggerated anatomic relationships and physiologic changes in the hematologic system favoring thrombogenesis. Because this condition is both underrecognized and underrepor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiovascular development and disease 2022-11, Vol.9 (12), p.410
Main Authors: Schrufer-Poland, Tabitha L, Florio, Karen, Grodzinsky, Anna, Borsa, John J, Schmidt, Laura
Format: Article
Language:English
Subjects:
Apixaban
Aspirin
Asymptomatic
Blood clots
Catheters
Cockett Syndrome
Compression therapy
iliac compression
May Thurner
Obstetrics
Patients
Pelvis
Pregnancy
Pregnant women
Rivaroxaban
Stents
Strategic planning (Business)
Thrombosis
Ultrasonic imaging
Uterus
Vagina
Veins & arteries
venous thromboembolism
Vertebrae
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:May Thurner Syndrome contributes to thromboembolic disease and can cause significant morbidity in pregnant patients secondary to exaggerated anatomic relationships and physiologic changes in the hematologic system favoring thrombogenesis. Because this condition is both underrecognized and underreported, management in pregnant and postpartum patients is based on expert opinion without any formal evidence-based guidance. Herein, we review five pregnancies in four patients with May Thurner Syndrome and general management strategies. Through collaborative and multidisciplinary care, patients with May Thurner Syndrome can be safely and successfully managed during pregnancy and the postpartum period with appropriate anticoagulation.
ISSN:2308-3425
2308-3425
DOI:10.3390/jcdd9120410